source
- Capricor plans FDA amendment after advisory committee rejects cardiomyopathy endpoint, stock jumpsCapricor Therapeutics received a negative vote from an FDA advisory committee on the efficacy of its cell therapy, deramiocel, for treating cardiomyopathy in Duchenne muscular dystrophy. The nine‑t…
- Opinion: Car telematics warns of health-insurance data surveillanceSociologists Andréa Becker and Paul Kamuf argue that the telematics model used in auto insurance could become a template for health‑insurance data collection. They describe how drivers’ minute‑by‑…